NETRF’s 2024 Margie & Robert E. Petersen Research Symposium was held on October 28-30 at the Hotel Commonwealth in Boston, Massachusetts. The 2024 Symposium featured 30 presentations by premier neuroendocrine cancer researchers from around the world. Oral presentations were divided by NET topic focus, resulting in five sessions, each hosted by two moderators with talks covering basic, translational, and clinical research projects.
Ramesh Shivdasani, MD, PhD delivered a keynote address, titled “Viewing Intestinal NETs Through the Lens of Normal Human Enteroendocrine Cell Differentiation”
Dr. Shivdasani received the Distinguished Service Award at the 2024 Symposium:
NETRF is proud to recognize Ramesh Shivdasani, MD, PhD, with the Distinguished Service Award. Dr. Shivdasani served as the Chair of NETRF’s Board of Scientific Advisors from 2007 to 2016. He has been active on the Board of Scientific Advisors since its inception and just recently was named as an Emeritus Member. During his impressive tenure, his expertise, leadership, and unwavering commitment have been instrumental in NETRF’s growth and advancement of our mission to accelerate research and improve outcomes for those affected by neuroendocrine cancer.
Dr. Shivdasani is known for his research on the cell of origin in intestinal neuroendocrine tumors, as well as his collaboration with other NETRF-funded researchers which yielded the discovery of non-functional PanNET subtypes characterized by different risks of recurrence.
Dr. Shivdasani is Professor of Medicine at Harvard Medical School; Professor of Medicine, Medical Oncology at the Dana-Farber Cancer Institute; and Deputy Director of the Dana-Farber/Harvard Cancer Center, Executive Committee. Until 2017, Dr. Shivdasani maintained a part-time practice in gastrointestinal oncology.
